Visteon (VC) Chief Accounting Officer granted performance rights and RSUs

Rhea-AI Filing Summary

Visteon Corp Chief Accounting Officer Colleen Elizabeth Myers received new equity awards. On March 1, 2026, she acquired 862 Performance Rights and 862 Restricted Stock Units at no purchase price. A separate line reflects 243 shares of common stock held directly after the reported transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Myers Colleen Elizabeth

(Last) (First) (Middle)

VISTEON CORPORATION

ONE VILLAGE CENTER DRIVE

(Street)

VAN BUREN TOWNSHIP MI 48111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VISTEON CORP [ VC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								243	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Rights	(1)	03/01/2026		A		862		(1)	02/28/2029	Common Stock	862	$0	862	D
Restricted Stock Units	(2)	03/01/2026		A		862		(2)	03/15/2028	Common Stock	862	$0	862	D

Explanation of Responses:

1. Each performance right represents a contingent right to receive one share of Visteon common stock. The vesting of the performance right is based on relative shareholder return and return on invested capital metrics over a three year performance period and payable in stock, subject to tax withholding.

2. Restricted Stock Units vest to the extent of 33% of the units granted on the following March 15th of each year after the date of grant. Each Restricted Stock Unit will be converted and distributed to me, without payment, in stock upon vesting and based upon the then current market value of a share of Visteon common stock, subject to tax withholding.

Remarks:

	Heidi A. Sepanik, Corporate Secretary, Visteon Corporation on behalf of Colleen E. Myers	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Visteon (VC) executive Colleen Myers receive?

Colleen Myers received two types of equity awards on March 1, 2026: 862 Performance Rights and 862 Restricted Stock Units. Both were granted at no purchase price and are structured to deliver Visteon common stock if vesting conditions are met.

How do the Performance Rights granted to Colleen Myers at Visteon (VC) vest?

Each Performance Right represents a contingent right to one Visteon common share. Vesting depends on relative shareholder return and return on invested capital over a three-year performance period, with payout in stock subject to tax withholding once conditions are satisfied.

What are the vesting terms of Colleen Myers’ Restricted Stock Units at Visteon (VC)?

The Restricted Stock Units vest 33% each March 15 following the grant date. Upon vesting, each unit is converted into Visteon common stock, delivered without payment, based on then-current market value, and is subject to applicable tax withholding requirements.

What is Colleen Myers’ common stock position reported in this Visteon (VC) Form 4?

The filing shows Colleen Myers directly holding 243 shares of Visteon common stock after the reported transactions. This line reflects her post-transaction common stock balance, separate from the newly granted Performance Rights and Restricted Stock Units described in the same report.

What role does Colleen Myers hold at Visteon (VC) in this insider filing?

Colleen Myers is identified as Visteon’s Chief Accounting Officer. Her position explains why she is a reporting person for insider transactions, including the March 1, 2026 grants of Performance Rights and Restricted Stock Units disclosed in this Form 4 filing.